Mounjaro 5 mg is prescribed by an endocrinologist for patients with the following goals: 🔹 Type 2 Diabetes Mellitus: Long-term treatment to maintain target glucose and glycated hemoglobin (HbA1c) levels. 🔹 Obesity Treatment: Weight reduction and management in adult patients with a BMI ≥30 kg/m² or ≥27 kg/m² in the presence of accompanying risk factors (diabetes, hypertension, apnea).

Dosage and administration

Sales Form: 1 multi-dose KwikPen (2.4 ml of solution) containing 4 doses of 5 mg.⚠️ INSTRUCTIONS FOR USE: Dosage Regimen: The drug is administered once a week. The 5 mg dosage is often a maintenance or intermediate step when titrating doses up to 7.5 mg, 10 mg, or 15 mg. Method of Administration: Subcutaneous injection into the abdomen, front of the thigh, or upper arm. It is recommended to rotate the injection site each week. Timing: On any day of the week at any time, regardless of food. It is advisable to choose a fixed day of the week. Storage: Store the unused pen in the refrigerator (2°C–8°C). Do not freeze! After the first injection, the pen can be stored at room temperature (up to 30°C) for up to 21 days.

⛔ Hereditary Risks: Personal or family history of medullary thyroid carcinoma. ⛔ Endocrine Disorders: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). ⛔ Pregnancy and Breastfeeding: Use is not recommended. Women of childbearing age should use reliable methods of contraception. ⛔ Type of Diabetes: Not used for type 1 diabetes mellitus. Serious kidney or gastrointestinal diseases (severe gastroparesis).

Side effects are often temporary and appear during the period of adaptation to the 5 mg dosage: 🤢 Digestive System (frequent): Nausea, diarrhea, vomiting, dyspepsia, epigastric pain, constipation. 🍽️ Appetite: Pronounced reduction in hunger, leading to rapid satiety. 🏃♂️ General: Feeling of fatigue, weakness, dizziness. 💉 Injection Site Reactions: Itching or slight redness of the skin. ⚠️ Serious Warnings: Risk of pancreatitis, dehydration due to vomiting (it is important to maintain hydration), potential gallbladder problems.

Mounjaro KwikPen 5 — Tirzepatide 5 mg, 1 pcs, Eli Lilly India

100% original product

Active ingredient

Tirzepatide

Manufacturer

Eli Lilly India

Dosage 5 mg

Dosage form Prefilled pen

Pens per pack 1

Mounjaro KwikPen 5 — Tirzepatide 5 mg (1 Pen / 4 Doses)

Name: Mounjaro KwikPen 5
Brand: Eli Lilly India
SKU: PROD-268
Price: 18093 UAH
Availability: InStock

18093₴ ~~19416₴~~ -7%

Mounjaro KwikPen 5 mg (Tirzepatide) is an innovative injectable medication for the treatment of type 2 diabetes and effective weight reduction. Tirzepatide is the world's first dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By simultaneously acting on two types of hormones, Mounjaro provides superior blood sugar control and promotes significant weight loss compared to previous generation drugs.

Manufacturer: Eli Lilly. The KwikPen format is a convenient multi-dose pre-filled pen designed to ensure dosing precision and ease of administration. The 5 mg dosage is typically the next step after the initial adaptation phase (2.5 mg) and allows for a more pronounced therapeutic effect.

Key Features:

✅ Dual Action: The synergy of GIP and GLP-1 receptors not only normalizes insulin but also effectively suppresses hunger at the level of the central nervous system.
✅ KwikPen Convenience: One pen contains 4 doses of 5 mg each, designed for a full month of therapy (one injection per week).
✅ Metabolic Control: The drug helps reduce body fat, improves lipid profiles, and lowers the burden on the cardiovascular system.

Mounjaro 5 mg is prescribed by an endocrinologist for patients with the following goals:

🔹 Type 2 Diabetes Mellitus: Long-term treatment to maintain target glucose and glycated hemoglobin (HbA1c) levels.
🔹 Obesity Treatment: Weight reduction and management in adult patients with a BMI ≥30 kg/m² or ≥27 kg/m² in the presence of accompanying risk factors (diabetes, hypertension, apnea).

Sales Form: 1 multi-dose KwikPen (2.4 ml of solution) containing 4 doses of 5 mg.

⚠️ INSTRUCTIONS FOR USE:

Dosage Regimen: The drug is administered once a week. The 5 mg dosage is often a maintenance or intermediate step when titrating doses up to 7.5 mg, 10 mg, or 15 mg.
Method of Administration: Subcutaneous injection into the abdomen, front of the thigh, or upper arm. It is recommended to rotate the injection site each week.
Timing: On any day of the week at any time, regardless of food. It is advisable to choose a fixed day of the week.
Storage: Store the unused pen in the refrigerator (2°C–8°C). Do not freeze! After the first injection, the pen can be stored at room temperature (up to 30°C) for up to 21 days.

⛔ Hereditary Risks: Personal or family history of medullary thyroid carcinoma.
⛔ Endocrine Disorders: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
⛔ Pregnancy and Breastfeeding: Use is not recommended. Women of childbearing age should use reliable methods of contraception.
⛔ Type of Diabetes: Not used for type 1 diabetes mellitus.
Serious kidney or gastrointestinal diseases (severe gastroparesis).

Side effects are often temporary and appear during the period of adaptation to the 5 mg dosage:

🤢 Digestive System (frequent): Nausea, diarrhea, vomiting, dyspepsia, epigastric pain, constipation.
🍽️ Appetite: Pronounced reduction in hunger, leading to rapid satiety.
🏃‍♂️ General: Feeling of fatigue, weakness, dizziness.
💉 Injection Site Reactions: Itching or slight redness of the skin.
⚠️ Serious Warnings: Risk of pancreatitis, dehydration due to vomiting (it is important to maintain hydration), potential gallbladder problems.